Pay in 4 interest-free payments of $7.41 Learn more
Ships within 48 hours · Estimated delivery Sep 30 - Oct 5
Patients are encouraged to adopt healthy lifestyle changes alongside medication to support long-term weight management
AOD-9604's entire human trial program involved 893 participants across six studies, with the largest being the 536-subject Phase 2b trial that failed to meet its endpoint
In the Phase 2b NATIVE trial, lanifibranor showed meaningful improvement in liver fibrosis but caused mean weight gain of 2.4-2.7 kg, peripheral edema, and anemia
It has been found to reduce the appearance of wrinkles and fine lines, improve skin tone and texture, and diminish the visibility of age spots, sun spots, and other forms of discoloration
US$ 25.18
US$ 20.15
.png?sfvrsn=f94c669f_5)
US$ 29.74
US$ 21.20
US$ 21.56
